Uterine Neoplasms
44
5
9
24
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.4%
5 terminated out of 44 trials
82.8%
-3.7% vs benchmark
5%
2 trials in Phase 3/4
21%
5 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (44)
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Anterior Quadratus Lumborum Block as a Component of Multimodal Analgesia for Abdominal Hysterectomies
Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study
Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
Evaluation of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Uterine Neoplasms
Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer.
RT for Cervical Adenocarcinoma/adenosquamous Carcinoma
Pre-Clinical Models in Gynecological Tumors A Tissue Repository
Sentinel Node Mapping in Women With Endometrial and Cervical Cancer
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial
Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis
Combidex USPIO - Ultra-small Superparamagnetic Iron Oxide
Sentinel Node Mapping in Women With Cervical and Endometrial Cancer
Retrospective Study of Brachytherapy
Early Feasibility Study of the "Easy Light" Fluorecence Imaging System
ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy.
Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer